172 related articles for article (PubMed ID: 20623786)
21. [Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].
Zhao SJ; Wu N; Zheng R; Liu Y; Zhang WJ; Liang Y; Zhang H; Li XM
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):754-7. PubMed ID: 24378097
[TBL] [Abstract][Full Text] [Related]
22. Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.
Lin MY; Wu M; Brennan S; Campeau MP; Binns DS; MacManus M; Solomon B; Hicks RJ; Fisher RJ; Ball DL
J Thorac Oncol; 2014 Mar; 9(3):377-82. PubMed ID: 24518089
[TBL] [Abstract][Full Text] [Related]
23. Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer.
Castillo R; Pham N; Ansari S; Meshkov D; Castillo S; Li M; Olanrewaju A; Hobbs B; Castillo E; Guerrero T
Radiat Oncol; 2014 Mar; 9():74. PubMed ID: 24625207
[TBL] [Abstract][Full Text] [Related]
24. High FDG uptake predicts poorer survival in locally advanced nonsmall cell lung cancer patients undergoing curative radiotherapy, independently of tumor size.
Ulger S; Demirci NY; Eroglu FN; Cengiz HH; Tunc M; Tatci E; Yilmaz U; Cetin E; Avci E; Cengiz M
J Cancer Res Clin Oncol; 2014 Mar; 140(3):495-502. PubMed ID: 24474555
[TBL] [Abstract][Full Text] [Related]
25. Predicting tumor hypoxia in non-small cell lung cancer by combining CT, FDG PET and dynamic contrast-enhanced CT.
Even AJG; Reymen B; La Fontaine MD; Das M; Jochems A; Mottaghy FM; Belderbos JSA; De Ruysscher D; Lambin P; van Elmpt W
Acta Oncol; 2017 Nov; 56(11):1591-1596. PubMed ID: 28840770
[TBL] [Abstract][Full Text] [Related]
26. Delineation of lung cancer with FDG PET/CT during radiation therapy.
Ganem J; Thureau S; Gardin I; Modzelewski R; Hapdey S; Vera P
Radiat Oncol; 2018 Nov; 13(1):219. PubMed ID: 30419929
[TBL] [Abstract][Full Text] [Related]
27. [Outcome after PET-CT based radiotherapy for non-small cell lung cancer].
Socha J; Kołodziejczyk M; Kępka L
Pneumonol Alergol Pol; 2013; 81(1):30-9. PubMed ID: 23258469
[TBL] [Abstract][Full Text] [Related]
28. Accuracy of fluorodeoxyglucose-positron emission tomography within the clinical practice of the American College of Surgeons Oncology Group Z4031 trial to diagnose clinical stage I non-small cell lung cancer.
Grogan EL; Deppen SA; Ballman KV; Andrade GM; Verdial FC; Aldrich MC; Chen CL; Decker PA; Harpole DH; Cerfolio RJ; Keenan RJ; Jones DR; D'Amico TA; Shrager JB; Meyers BF; Putnam JB
Ann Thorac Surg; 2014 Apr; 97(4):1142-8. PubMed ID: 24576597
[TBL] [Abstract][Full Text] [Related]
29. The management impact of clinically significant incidental lesions detected on staging FDG PET-CT in patients with non-small cell lung cancer (NSCLC): an analysis of 649 cases.
Lin M; Ambati C
Lung Cancer; 2012 Jun; 76(3):344-9. PubMed ID: 22206598
[TBL] [Abstract][Full Text] [Related]
30. A new method to assess pulmonary changes using
Abravan A; Knudtsen IS; Eide HA; Løndalen AM; Helland Å; van Luijk P; Malinen E
Acta Oncol; 2017 Nov; 56(11):1597-1603. PubMed ID: 28849707
[TBL] [Abstract][Full Text] [Related]
31. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
[TBL] [Abstract][Full Text] [Related]
32. Screening for brain metastases in patients with stage III non-small cell lung cancer: Is there additive value of magnetic resonance imaging above a contrast-enhanced computed tomography of the brain?
Hendriks LE; Bootsma GP; de Ruysscher DK; Scheppers NA; Hofman PA; Brans BT; Dingemans AM
Lung Cancer; 2013 Jun; 80(3):293-7. PubMed ID: 23518381
[TBL] [Abstract][Full Text] [Related]
33. Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.
Chaft JE; Dunphy M; Naidoo J; Travis WD; Hellmann M; Woo K; Downey R; Rusch V; Ginsberg MS; Azzoli CG; Kris MG
J Thorac Oncol; 2016 Apr; 11(4):537-44. PubMed ID: 26724474
[TBL] [Abstract][Full Text] [Related]
34. Metabolic tumor burden quantified on [
Lapa P; Oliveiros B; Marques M; Isidoro J; Alves FC; Costa JMN; Costa G; de Lima JP
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2169-2178. PubMed ID: 28785842
[TBL] [Abstract][Full Text] [Related]
35. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer.
Gensheimer MF; Hong JC; Chang-Halpenny C; Zhu H; Eclov NCW; To J; Murphy JD; Wakelee HA; Neal JW; Le QT; Hara WY; Quon A; Maxim PG; Graves EE; Olson MR; Diehn M; Loo BW
Radiother Oncol; 2017 Nov; 125(2):338-343. PubMed ID: 28830717
[TBL] [Abstract][Full Text] [Related]
36. Primary tumor standardized uptake value measured on F18-Fluorodeoxyglucose positron emission tomography is of prediction value for survival and local control in non-small-cell lung cancer receiving radiotherapy: meta-analysis.
Na F; Wang J; Li C; Deng L; Xue J; Lu Y
J Thorac Oncol; 2014 Jun; 9(6):834-42. PubMed ID: 24787963
[TBL] [Abstract][Full Text] [Related]
37. PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment.
Iravani A; Turgeon GA; Akhurst T; Callahan JW; Bressel M; Everitt SJ; Siva S; Hofman MS; Hicks RJ; Ball DL; Mac Manus MP
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1869-1877. PubMed ID: 31190177
[TBL] [Abstract][Full Text] [Related]
38. Respiratory-gated (4D) FDG-PET detects tumour and normal lung response after stereotactic radiotherapy for pulmonary metastases.
Siva S; Callahan JW; Kron T; Chesson B; Barnett SA; Macmanus MP; Hicks RJ; Ball DL
Acta Oncol; 2015; 54(8):1105-12. PubMed ID: 25833329
[TBL] [Abstract][Full Text] [Related]
39. Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT.
Kandi M; Hoffmann L; Sloth Moeller D; Schmidt HH; Knap MM; Khalil AA
Acta Oncol; 2018 Jun; 57(6):813-819. PubMed ID: 29205088
[TBL] [Abstract][Full Text] [Related]
40. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy.
Ashley Cox R; Akhurst T; Bressel M; MacManus M; Ball D
Radiother Oncol; 2017 Jul; 124(1):25-30. PubMed ID: 28662870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
